Menopause Care in Ireland Has Changed

Menopause Care in Ireland Has Changed

Two things happened in 2025 that reshaped menopause treatment options in Ireland. First, the HSE rolled out free Hormone Replacement Therapy at participating pharmacies from June 1st, removing prescription charges for women registered with the Drugs Payment Scheme or holding a medical card. Second, the “Menopause Dialogues — The Census” study, commissioned by CanesMeno and released in October 2025, found that 92% of Irish women experience menopause symptoms, and a staggering number report that their symptoms are poorly managed or dismissed outright. Together, these developments have turned a quiet revolution into a real one. Irish women now have better access to treatment than at any point in the last two decades, but knowing how the system actually works — where to go, what you’ll get, what it costs — is still the difference between getting care and getting frustrated.

Free HRT in Ireland: How the Scheme Actually Works

Budget 2025 allocated funding for free HRT, and from January 1st 2025 the medication itself became free at dispensing pharmacies. A further expansion on June 1st 2025 removed the prescription charge as well for eligible women. That means if you are registered for the Drugs Payment Scheme (€80 monthly cap on all medicines) or hold a medical card, your HRT costs nothing at the counter. The scheme covers the vast majority of body-identical HRT products on the Irish market — Estradot patches, Sandrena gel, Oestrogel, Utrogestan capsules, and others. A small number of less common brands may not be included; your pharmacist will tell you at the point of dispensing. The key point you need to understand: you still need a valid prescription from a GP, gynaecologist, or other registered prescriber. The scheme covers the medicine, not the consultation.

What about women who don’t qualify for medical cards or the Drugs Payment Scheme? They still pay for the prescription, but the medication itself is free under the scheme from participating pharmacies. The Irish government removed VAT from HRT products in Budget 2023, so even without full scheme eligibility, the cost has already dropped significantly over the last three years.

Body-Identical HRT Is Now the Irish Standard

Modern prescribing in Ireland has shifted firmly toward body-identical HRT. Transdermal oestrogen — delivered through patches like Estradot and Evorel, or gels like Sandrena and Oestrogel — bypasses the liver on first pass, which means a lower blood clot risk than oral tablets. This matters because the old WHI scare of 2002 was driven by oral conjugated equine oestrogens in women over 65. Transdermal routes effectively eliminate that elevated clot risk. For women with a uterus, micronised progesterone (Utrogestan, taken at night because it has a mild sedative effect) provides endometrial protection. The Mirena IUS is another common choice in Ireland — it delivers progestogen directly to the womb lining and doubles as contraception, which is relevant because HRT is not contraception, and Irish women under 55 still need separate birth control unless they have a Mirena in place.

The Menopause Society of Ireland, alongside the International Menopause Society’s 2024 recommendations, endorses this body-identical approach as first-line therapy. Combined oral preparations like Femoston are still prescribed but carry a slightly higher VTE risk than transdermal routes. Tibolone (Livial) remains available for post-menopausal women who want a single-tablet option.

Specialist Menopause Clinics in Ireland

Ireland has three designated specialist complex menopause clinics, all in Dublin. The National Maternity Hospital at Holles Street runs a dedicated service for women with complex histories — premature ovarian insufficiency, breast cancer survivors, women who cannot take standard HRT. The Rotunda Hospital’s menopause clinic is another referral centre, and the Coombe Hospital operates a third. These are not walk-in services. Your GP must refer you, and the clinics only accept cases that cannot be managed in primary care — women whose symptoms haven’t responded to treatment, who have contraindications to HRT, or who need multidisciplinary input from gynaecology, cardiology, and oncology simultaneously.

For the majority of Irish women, GP-led care is entirely sufficient. The HSE’s 2026 patient management guide, endorsed by the British Menopause Society, confirms that most women can be assessed, prescribed, and followed up entirely through their GP. The average menopause age in Ireland is 51, and most women enter perimenopause in their mid-40s. A GP with a good menopause history can diagnose without blood tests in women over 45 presenting with typical symptoms.

Menopause Treatment with Vaginal Oestrogen: The Most Under-Prescribed Option in Irish Primary Care

Vaginal oestrogen deserves its own section because it is systematically under-prescribed in Ireland. Genitourinary Syndrome of Menopause — vaginal dryness, painful sex, recurrent urinary tract infections, urinary urgency — affects roughly half of post-menopausal women. Vaginal oestrogen (Vagifem pessaries, Imvaggis cream, the Estring ring) delivers a low dose locally with negligible systemic absorption. No progesterone is needed to protect the womb lining. The HSE explicitly states these symptoms “do not go away with time” and will return when treatment stops, meaning long-term use is the norm. This is safe — side effects are very rare. Crucially, vaginal oestrogen can be used alongside or instead of systemic HRT, and after specialist discussion, many breast cancer survivors can also use it.

At the October 2025 “Menopause Dialogues” release, Dr. Nóirín O’Herlihy of the ICGP noted that vaginal oestrogen remains “one of the most effective and safest treatments we have, and yet it is still not being offered routinely.” If your GP does not mention it and you have any GSM symptoms — dryness, painful intercourse, recurrent UTIs — you should ask for it explicitly.

Follow-Up and the 3-Month Review

The HSE’s protocol requires a follow-up appointment three months after starting any menopause treatment, then annually after that. At the three-month review your GP will check symptom control, bleeding patterns (if you’re still perimenopausal), weight, and blood pressure. They may adjust your dose or switch delivery methods. This is also when you discuss whether you want to continue, stop, or transition to a different regimen. Most women need treatment for several years, until the most severe symptoms subside — typically between ages 51 and 55, but some continue into their 60s if symptoms persist.

A 2025 study led by the University of Galway, published in the Irish Times in October 2025, found that women who take HRT after menopause are less likely to develop dementia. This landmark finding adds weight to the argument that HRT’s benefits extend beyond symptom relief into long-term neurological protection, at least for women who start treatment near the onset of menopause.

How to Get Menopause Treatment in Ireland

Start with your GP. Book a consultation specifically to discuss perimenopause or menopause. Bring a symptom diary if you have one. Be explicit about what is affecting your quality of life — disrupted sleep, mood changes, vaginal discomfort, hot flushes that interfere with work or social life. Irish GPs are increasingly trained in menopause management, and the ICGP maintains a dedicated menopause resource list for practitioners. If your GP is dismissive or tells you symptoms are “just part of getting older,” find another doctor. The Understanding Menopause guide can help you prepare for that conversation with the right questions.

For women who prefer an online route, several Irish-registered telehealth services now offer menopause consultations with IMC-registered doctors who can prescribe HRT, vaginal oestrogen, and arrange follow-up. These services are particularly useful if your local GP has limited menopause experience or long waiting times. Whichever route you choose, the complete HRT guide and hormone replacement therapy overview on this site can help you understand what options exist before you walk into the appointment.

  • HSE Menopause Treatment page — official government resource
  • Citizens Information — free HRT scheme eligibility details
  • Menopause Society of Ireland — professional guidelines and member resources
  • ICGP Menopause Resource List — for finding trained GPs
  • “Menopause Dialogues — The Census” (CanesMeno/Bayer, October 2025) — 92% of Irish women report symptoms
  • University of Galway HRT and Dementia Study (October 2025) — HRT linked to lower dementia risk